Prolactin and fMRI response to SKF38393 in the baboon

PeerJ

Volumn 2013, Issue 1, 2013, Pages

  Miller, Brad ^a   Marks, Lauren A ^a   Koller, Jonathan M ^a   Newman, Blake J ^a   Bretthorst, G Larry ^a   Black, Kevin J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine D1 receptor agonists; fMRI; Isoflurane; Ketamine; Papio anubis; Pharmacological fMRI; Pramipexole; Prolactin; SKF38393; SKF82958

Indexed keywords

2, 3, 4, 5 TETRAHYDRO 7, 8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 ALLYL 6 CHLORO 2, 3, 4, 5 TETRAHYDRO 7, 8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ISOFLURANE; KETAMINE; PRAMIPEXOLE; PROLACTIN; UNCLASSIFIED DRUG;

ADULT; AGE; ANIMAL EXPERIMENT; ARTICLE; BABOON; BOLD SIGNAL; DRUG DOSE INCREASE; DRUG RESPONSE; ENDOTRACHEAL INTUBATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; MALE; NONHUMAN; RADIOIMMUNOASSAY;

EID: 84888390809     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.195     Document Type: Article

References (64)

1. Aubert ML, Grumbach MM, Kaplan SL. 1974. Heterologous radioimmunoassay for plasma human prolactin (hPRL): values in normal subjects, puberty, pregnancy and in pituitary disorders. Acta Endocrinologica 77:460-476
2. Ben-jonathan N, Hnasko R. 2001. Dopamine as a prolactin (PRL) inhibitor. Endocrine Reviews 22:724-763
3. 1 receptor ligands: drug interaction studies in squirrel monkeys. Journal of Pharmacology and Experimental Therapeutics 276:942-950
4. 2 receptor-mediated changes in striatopallidal function. Journal of Neuroscience 17(9):3168-3177
5. 1 agonist activates temporal lobe structures in primates. Journal of Neurophysiology 84:549-557
6. 3-preferring dopamine agonist. Proceedings of the National Academy of Sciences of the United States of America 99:17113-17118
7. Black KJ, Hershey T, Moerlein SM, Perlmutter JS. 2009. Neuroimaging in baboons. In: VandeBerg JL, Williams-Blangero S, Tardif SD, eds. The baboon in biomedical research. New York: Springer. 327-350
8. Black KJ, Koller JM, Campbell MC, Gusnard DA, Bandak SI. 2010. Quantification of indirect pathway inhibition by the adenosine A2a antagonist SYN115 in Parkinson disease. Journal of Neuroscience 30:16284-16292
9. Black KJ, Koller JM, Miller BD. 2013. Rapid quantitative pharmacodynamic imaging by a novel method: theory, simulation testing and proof of principle. PeerJ 1:e117
10. Black KJ, Snyder AZ, Koller JM, Gado MH, Perlmutter JS. 2001. Template images for nonhuman primate neuroimaging 1. Baboon. NeuroImage 14(3):736-743
11. Bretthorst GL. 1988. Bayesian spectrum analysis and parameter estimation. New York: Springer-Verlag. vol. 48
12. Bretthorst GL, Marutyan K. 2012. Bayesian Analysis of Common NMR Problems, v. 4.0 (software). Available at http://bayesiananalysis.wustl.edu (accessed 08 May 2013)
13. 2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland. Neuroendocrinology 54:175-183
14. Chen YCI, Galpern WR, Brownell AL, Matthews RT, Bogdanov M, Isacson O, Keltner JR, Beal MF, Rosen BR, Jenkins BG. 1997. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magnetic Resonance in Medicine 38:389-398
15. 1 dopamine receptors that stimulate prolactin release in the rat pituitary. European Journal of Pharmacology 142:425-429
16. 1 receptors are involved in the stimulation of prolactin secretion by high environmental temperature on the female sheep. Journal of Neuroendocrinology 10:503-509
17. Crozier TA, Múller JE, Quittkat D, Sydow M, Wuttke W, Kettler D. 1994. Effect of anaesthesia on the cytokine responses to abdominal surgery. British Journal of Anesthesia 72:280-285
18. 1 receptor analogues act centrally to stimulate prolactin secretion in ewes. Journal of Endocrinology 137:457-464
19. Davis R, Huffman RD. 1968. A stereotaxic atlas of the brain of the baboon. Austin, Texas: University of Texas Press.
20. 1 agonist and antagonist on the rat brain as determined using BOLD fMRI. Proc. Intl. Soc. Mag. Reson. Med. 9:1340
21. 2 receptors in the regulation of hypothalamic tuberoinfundibular dopamine neurons. European Journal of Pharmacology 355:141-147
22. Ehara Y, Yen SSC, Siler TM. 1975. Serum prolactin levels during puberty. American Journal of Obstetrics and Gynecology 121:995-997
23. 2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion. Neuroscience 54:1051-1061
24. Fabbrini G, Braun A, Mouradian MM, Tamminga CA, Chase TN. 1988. Dopamine D-1 receptor agonist stimulation of prolactin secretion in man. Journal of Neural Transmission 71:159-163
25. Finkelstein JW, Kapen S, Weitzman ED, Hellman L, Boyar RM. 1978. Twenty-four-hour plasma prolactin patterns in prepubertal and adolescent boys. Journal of Clinical Endocrinology & Metabolism 47:1123-1128
26. Freeman ME, Kanyicska B, Lerant A, Nagy G. 2000. Prolactin: structure, function, and regulation of secretion. Physiological Reviews 80:1523-1631
27. 1 agonists in human caudate: biochemical properties and therapeutic implications. Neuropharmacology 34:481-488
28. Guyda HJ, Friesen HG. 1973. Serum prolactin levels in humans from birth to adult life. Pediatric Research 7:534-540
29. Hayashi T, Tadokoro S. 1984. Parallelism between avoidance-suppressing and prolactin-increasing effects of antipsychotic drugs in rats. Japanese Journal of Pharmacology 35:451-456
30. Hergovich N, Singer E, Agneter E, Eichler HG, Graselli U, Simhandl C, Jilma B. 2001. Comparison of the effects of ketamine and memantine on prolactin and cortisol release in men: a randomized, double-blind, placebo-controlled trial. Neuropsychopharmacology 24:590-593
31. Herscovitch P. 2001. Can [15O]water be used to evaluate drugs? Journal of Clinical Pharmacology 41:11S-20S.
32. Hershey T, Black KJ, Carl JL, Mcgee-minnich L, Snyder AZ, Perlmutter JS. 2003. Long term treatment and disease severity change brain responses to levodopa in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 74:844-851
33. Hershey T, Black KJ, Carl JL, Perlmutter JS. 2000. Dopa-induced blood flow responses in non-human primates. Experimental Neurology 166:342-349
34. Holford NHG, Sheiner LB. 1982. Kinetics of pharmacologic response. Pharmacology and Therapeutics 16:143-166
35. 3 desensitisation following successful treatment with serotonergic antidepressants. Journal of Psychopharmacology 24:709-716
36. Jaber M, Robinson SW, Missale C, Caron MG. 1996. Dopamine receptors and brain function. Neuropharmacology 35:1503-1519
37. Kondo M, Udono T, Jin W, Shimizu K, Funakoshi M, Itoh M, Watanabe G, Groome NP, Taya K. 2000. Changes in plasma concentrations of inhibin A and inhibin B throughout sexual maturation in the male chimpanzee. Endocrine Journal 47:707-714
38. Leblanc H, Lachelin GC, Abu-fadil S, Yen SS. 1976. Effects of dopamine infusion on pituitary hormone secretion in humans. Journal of Clinical Endocrinology & Metabolism 43:668-674
39. Lee PA, Jaffe RB, Midgley AR. 1974. Serum gonadotropin, testosterone and prolactin concentrations throughout puberty in boys: a longitudinal study. Journal of Clinical Endocrinology and Metabolism 39:664-672
40. Marana E, Annetta MG, Meo F, Parpaglion R, Galeone M, Maussier ML, Marana R. 2003. Sevoflurane improves the neuroendocrine stress response during laparoscopic pelvic surgery. Canadian Journal of Anaesthesia 50:348-354
41. Mierau J. 1995. Pramipexole: a dopamine-receptor agonist for treatment of Parkinson's disease. Clinical Neuropharmacology 18:S195-S206
42. 3 and D4 receptors. European Journal of Pharmacology 290:29-36
43. 1 receptor stimulation in 6-OHDA lesioned rats: effect of sensitization (priming) with a dopaminergic agonist. Synapse 13:264-269
44. Norman RL, Quadri SK, Spies HG. 1980. Differential sensitivity of prolactin release to dopamine and thyrotrophin-releasing hormone in intact and pituitary stalk-sectioned rhesus monkeys. Journal of Endocrinology 84:479-487
45. Perlmutter JS, Rowe CC, Lich LL. 1993. In vivo pharmacological activation of dopaminergic pathways in primates studied with PET. Journal of Cerebral Blood Flow & Metabolism 13:S286
46. Phillips-conroy JE, Jolly CJ, Rogers J, Ziegler T. 2013. Serum prolactin and social behavior of Kindas and other baboons (poster abstract) American Journal of Physical Anthropology 150(Suppl 56):221 Available at http://meeting.physanth.org/program/2013/session18/phillips-conroy-2013-serum-prolactin-and-social-behavior-of-kindas-and-other-baboons.html
47. 3-preferring agonist useful in treating Parkinson's disease. Clinical Neuropharmacology 21:141-151
48. Porta F, Mussa A, Concolino D, Spada M, Ponzone A. 2009. Dopamine agonists in 6-pyruvoyl tetrahydropterin synthase deficiency. Neurology 73:633-637
49. Puri CP, Puri V, Anand Kumar TC. 1981. Serum levels of testosterone, cortisol, prolactin and bioactive luteinizing hormone in adult male rhesus monkeys following cage-restraint or anaesthetizing with ketamine hydrochloride. Acta Endocrinologica 97:118-124
50. Quadri SK, Pierson C, Spies HG. 1978. Effects of centrally acting drugs on serum prolactin levels in rhesus monkeys. Neuroendocrinology 27:136-147
51. Reber A, Huber PR, Ummenhofer W, Gürtler CM, Zurschmiede C, Drewe J, Schneider M. 1998. General anaesthesia for surgery can influence circulating melatonin during daylight hours. Acta Anaesthesiologica Scandinavica 42:1050-1056
52. Rizvi SSR, Altaf S, Naseem AA, Asif M, Rasul Z, Qayyum M. 2001. The effect of ketamine hydrochloride anesthesia on basal and N-methyl-D, L-aspartate induced plasma prolactin secretion in the adult male rhesus monkey. Life Science 68:1083-1093
53. Saller CF, Salama AI. 1986. D-1 dopamine receptor stimulation elevates plasma prolactin levels. European Journal of Pharmacology 122:139-142
54. Samuels ER, Hou RH, Langley RW, Szabadi E, Bradshaw CM. 2006. Comparison of pramipexole and amisulpride on alertness, autonomic and endocrine functions in healthy volunteers. Psychopharmacology 187:498-510
55. Schettini G, Mastronardi P, Scanni E, Pinto M, Forgione A, Florio T, Savastano S, Merola B, Lombardi G, Mazzarella B. 1989. Antiemetic effect of the levo isomer of sulpiride (L-sulpiride) in humans. Minerva Anestesiologica 55:239-243
56. Schilling JC, Adamus WS, Palluk R. 1992. Neuroendocrine and side effect profile of pramipexole, a new dopamine receptor agonist, in humans. Clinical Pharmacology and Therapeutics 51:541-548
57. Tanimoto K, Tamminga CA, Chase TN. 1987. Elevation of plasma prolactin concentrations by intravenous SCH 23390 and SKF 38393 in conscious rats. European Journal of Pharmacology 144:147-151
58. Trugman JM, James CL. 1992. Rapid development of dopaminergic supersensitivity in reserpine-treated rats demonstrated with 14C-2-deoxyglucose autoradiography. Journal of Neuroscience 12:2875-2879
59. 1 dopamine agonist and antagonist effects on regional cerebral glucose utilization in rats with intact dopaminergic innervation. Brain Research 607:270-274
60. Trugman JM, Wooten GF. 1986. The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigra. Brain Research 379:264-274
61. Vandeberg JL. 2009. Introduction. In: VandeBerg JL, Williams-Blangero S, Tardif SD, eds. The baboon in biomedical research. New York: Springer. xvii-xxiii
62. Walker ML. 1987. Effects of anesthetic agents on the adrenocortical system of female baboons. American Journal of Primatology 13:325-332
63. Wickings EJ, Nieschlag E. 1980. Pituitary response to LRH and TRH stimulation and peripheral steroid hormone in conscious and anaesthetized adult male rhesus monkeys (Macaca mulatta) Acta Endocrinologica 93:287-293
64. Zhang Z, Andersen AH, Avison MJ, Gerhardt GA, Gash DM. 2000. Functional MRI of apomorphine activation of the basal ganglia in awake rhesus monkeys. Brain Research 852:290-296